Donepezil for Down's syndrome

Am J Psychiatry. 2001 Jan;158(1):143. doi: 10.1176/appi.ajp.158.1.143.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / etiology
  • Alzheimer Disease / psychology
  • Cholinesterase Inhibitors / administration & dosage
  • Cholinesterase Inhibitors / adverse effects
  • Cholinesterase Inhibitors / therapeutic use*
  • Clinical Trials as Topic
  • Comorbidity
  • Donepezil
  • Dose-Response Relationship, Drug
  • Down Syndrome / drug therapy*
  • Down Syndrome / epidemiology
  • Down Syndrome / psychology
  • Drug Administration Schedule
  • Humans
  • Indans / administration & dosage
  • Indans / adverse effects
  • Indans / therapeutic use*
  • Middle Aged
  • Piperidines / administration & dosage
  • Piperidines / adverse effects
  • Piperidines / therapeutic use*
  • Treatment Outcome

Substances

  • Cholinesterase Inhibitors
  • Indans
  • Piperidines
  • Donepezil